SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.785-4.9%Nov 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (206)11/22/1999 6:13:00 PM
From: JMarcusRead Replies (1) of 557
 
I see that TGEN went out of its way to distance its AAV products from the Adenovirus vectors.

biz.yahoo.com

Bravo!

Mike, you've persuaded me that the run-up in Avigen's stock is getting a bit frothy. TGEN looks like a much better investment: its price is dirt cheap (not much downside risk), and to the extent Avigen establishes the viability of AAV as a gene therapy vector, TGEN should enjoy enjoy some of the upside from that good news. I sold some Avigen today and bought TGEN with the proceeds. I'm still bullish Avigen and kept the lion's share of my holdings, but I like the idea of diversification.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext